YM-254890

From WikiMD's Medical Encyclopedia

Revision as of 19:57, 8 March 2024 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

YM-254890 is a G protein-coupled receptor antagonist that is derived from the bacterium Chromobacterium violaceum. It is a highly selective inhibitor of the Gq alpha subunit of the G protein, and it has been used in the study of G protein signaling.

Structure and Function

The structure of YM-254890 is unique among G protein antagonists. It is a cyclic depsipeptide, meaning it contains both peptide and ester bonds. The molecule has a complex structure that includes a 22-membered ring and several unusual amino acids.

YM-254890 functions by binding to the Gq alpha subunit of the G protein, preventing it from interacting with G protein-coupled receptors on the cell surface. This inhibits the activation of the G protein and the subsequent intracellular signaling pathways it would normally initiate.

Pharmacological Applications

Because of its specificity for the Gq alpha subunit, YM-254890 has been used in research to study the role of this protein in various cellular processes. It has been particularly useful in studying G protein-coupled receptor signaling, as it allows researchers to selectively inhibit this pathway and observe the resulting effects on the cell.

In addition to its research applications, YM-254890 has potential therapeutic applications. Its ability to inhibit G protein signaling could make it useful in the treatment of diseases that are caused by overactive G protein-coupled receptor signaling, such as certain types of cancer.

See Also

References

<references />

This article is a stub related to pharmacology. You can help WikiMD by expanding it!


Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.